Replay available

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call

Neuronetics, Inc. (NASDAQ: STIM) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Tue, May 6, 2025 at 8:30 AMendedReplay
Neuronetics, Inc. (STIM) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Mark Klausner

Investor Relations

Keith Sullivan

President and Chief Executive Officer

Steve Furlong

Chief Financial Officer

Margaret Casler Andrew

Analyst, William Blair

William Blavnik

Analyst, Canaccord Genuity

Adam Mader

Analyst, Piper Sandler

Danny Staudter

Analyst, Citizens JMP

Replay transcript excerpt

2025 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Mark Klausner. Please go ahead. Good morning, and thank you for joining us for the Neuronetics first quarter of 2025 conference call. Joining me on today's call are Neuronetics President and Chief Executive Officer Keith Sullivan and Chief Financial Officer Steve Furlong. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our business, strategy, financial and revenue guidance, the Greenbrook acquisition, and other operational issues and metrics. Actual results can differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. For discussion of risks and uncertainties associated with the Neuronetics business, I encourage you to review the company's filings with the Securities and Exchange Commission, including the company's annual report on Form 10-K, which was filed in March. The company disclaims any obligation to update any forward-looking statements made during the course of this call, except as req...

More from Neuronetics, Inc.